MedPath

A Clinical study to compare the effects between two basti patterns, Chaturbhadra Kalpa Basti And Kala Basti in patients with Vataja Gridhrasi W.S.R to Sciatica

Not Applicable
Conditions
Health Condition 1: M543- Sciatica
Registration Number
CTRI/2022/03/040853
Lead Sponsor
Shri Vijay Mahantesh Ayurvedic Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Subjects presenting with Clinical Signs & Symptoms of Vataja Gridhrasi

2. Straight Leg Raising (SLR) test being positive.

3. Subject fit for Basti karma.

Exclusion Criteria

1. Subjects presenting with Clinical Signs & Symptoms of Vatakaphaja Gridhrasi.

2. Subjects suffering with T.B. Spine / Hip, tumors of spine, focal neuropathy and any septic or infectious disease of spine, History of Trauma / Traumatic lesion in lumbosacral region.

3. Subjects with other severe systemic disorder or multi systemic involvement and any concomitant serious illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To clinically evaluate the efficacy of chaturbhadra kalpa basti in Vataja gridhrasi. <br/ ><br>2. To clinically evaluate the efficacy of kala basti in vataja gridhrasi. <br/ ><br>3. To compare the efficacy of chaturbhadra kalpa basti and kala basti in vataja Gridhrasi. <br/ ><br> <br/ ><br>4.SUBJECTIVE PARAMETERS <br/ ><br> <br/ ><br>A.Ruk (Pain) <br/ ><br>B.Sthambha (Stiffness) <br/ ><br>C.Spandana (Tingling sensation) <br/ ><br>D.Toda (Pricking Sensation) <br/ ><br> <br/ ><br>5.OBJECTIVE PARAMETRES <br/ ><br> <br/ ><br>A.SLR Test. <br/ ><br>B.Tenderness <br/ ><br> <br/ ><br>Timepoint: The outcome of interventional group will be accessed on Before treatment, 13th day- After treatment & follow up of 30th & 45th day. <br/ ><br>The outcome of Comparator group (Ayurveda) will be accessed on Before treatment, 16th day - After treatment & follow up of 30th & 45th day. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
il <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: Nil <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath